Nexavar
Nexavar Official FDA information, side effects and uses.
Posted by Nexavar (Nexavar) on Sun, 29 Jul 2007 06:15:46 +0000
Information about Nexavar and its use in the treatment of the kidney cancer known as advanced renal cell carcinoma (RCC). From Bayer Pharmaceuticals and Onyx Pharmaceuticals.
Patient Information Sheet - Sorafenib (marketed as Nexavar)
Patient information sheet for the prescription Sorafenib, marketed as Nexavar, from the U.S. Food and Drug Administration.
Nexavar - Chemotherapy Drugs and Side Effects
Describes the side effects and precuations to be taken while undergoing treatment with the chemothrapy drug Nexavar (Sorafenib).
Nexavar (Sorafenib) drug description - prescription drugs and medications at RxList
Offers pharmacology, indications, dosage, side effects, and patient information for the prescription drug used to treat advanced renal cell carcinoma.
Nexavar Information from Drugs.com
Information about the medication Nexavar (Sorafenib), used to treat a type of kidney cancer, including its side effects and contraindications....
Posted by Nexavar (Nexavar) on Sun, 29 Jul 2007 00:15:39 +0000
| Decision is too late for cancer sufferer The Northern Echo, UK - Ironically, Mrs Devonport's consultant decided to put her on Nexavar, a similar drug to Sutent which is also licensed but can only be purchased privately. ... Kidney cancer drug decision hailed as 'major breakthrough' |
Bayer and Onyx submit supplemental NDA for Nexavar - News-Medical.net
| Bayer and Onyx submit supplemental NDA for Nexavar News-Medical.net, Australia - Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals have announced that a Supplemental New Drug Application (sNDA) for Nexavar (sorafenib) tablets has ... |
Bayer and Onyx Submit Supplemental New Drug Application for ... - MedIn... Original post: Decision is too late for cancer sufferer - The Northern Echo by ©2007 Google at nexavar - Google News
Posted by Nexavar (Nexavar) on Sat, 28 Jul 2007 21:16:46 +0000
Despite their popularity, these stocks are trading for less than they're worth.
Familiar TRAIL Followed To New Cancer Therapy (Medical News Today)
A new study identifies a combination therapy that may sensitize human cancer cells to a promising treatment currently being used in clinical trials. [click link for full article]
Before the Call: Gauging Genentech (The Motley Fool)
Quarter, schmorter. What's the big picture look like?
Scientists Follow Familiar 'TRAIL' To New Cancer Therapy (Science Daily)
A new study identifies a combination therapy that may sensitize human cancer cells to a promising treatment currently being used in clinical trials. The research provides a pharmacological method for enhancing the potency and effectiveness of a tumor necrosis factor death receptor ligand against a variety of human cancers.
Dow Jones Picks the Top 5 Hedge Fund Trades Thus Far (PR Newswire via Yahoo! Finance)
Despite the problems the industry faces from fractures in the sub-prime mortgage sector, some hedge funds continue to rake in big profits through astute stock trading, according to Hedge Fund Trades, the weekly e-newsletter from Dow Jones....
Posted by Nexavar (Nexavar) on Sat, 28 Jul 2007 18:17:15 +0000
The primary objective of the study was to compare overall survival in patients administered Nexavar versus those administered placebo. Median overall survival was 10.7 months in Nexavar-treated patients compared to 7.9 months in those ...
Nexavar prolongs survival among Liver cancer patients
The findings of a clinical trial presented by doctors at the American Society of Clinical Oncology meeting in Chicago on Monday provided hope to the deadly liver cancer patients as Nexavar, a drug developed by Onyx Pharmaceuticals Inc. ...
Bayer And Onyx Submit Supplemental New Drug Application For ...
(Nasdaq: ONXX) today announced that a Supplemental New Drug Application (sNDA) for Nexavar(R) (sorafenib) tablets has been submitted to the US Food and Drug Administration (FDA) for the treatment of patients with hepatocellular ...
Nexavar (sorafenib) and HCC
Data presented today at the 43rd annual meeting of the American Society of Clinical Oncology (ASCO) has shown that Nexavar (sorafenib) tablets significantly extended overall survival (OS) in patients with advanced hepatocellular ...
Liver Cancer Patients May Have 44% Higher Survival Rate By Nexavar
Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc. today announced that Nexavar tablets significantly extended overall survival in patients with hepatocellular carcinoma , or primary liver ... via Huliq.com....
Posted by Nexavar (Nexavar) on Sat, 28 Jul 2007 16:50:59 +0000
Jackson Clarion-Ledger - That's why doctors are excited about Nexavar, a pill first approved for kidney cancer in 2005, says Josep Llovet of Mount Sinai School of Medicine in New York, lead author of the new study. In an international study of 602 patients with hepatocellular ...
Chemo and Surgery May Help Colon Cancer
Newsday - Those results occurred in patients with advanced liver cancer treated with the drug sorafenib, or Nexavar, which is marketed by Bayer Pharmaceuticals Corp. and Onyx Pharmaceuticals Inc. to treat advanced kidney cancer. The companies are expected to ...
Bayer seeks liver cancer OK for Nexavar
United Press International - WAYNE, N.J., June 27 (UPI) -- Bayer and Onyx Wednesday filed a supplemental new drug application with the U.S. Food and Drug Administration for Nexavar for treating liver cancer. Nexavar, which is currently approved for treating advanced kidney ...
Fury over £84,000 NHS trip to Japan
This is North East - Ray Devonport, from Newton Aycliffe, County Durham, whose wife, Kathleen, 63, has been able to get access to an advanced kidney cancer drug - called Nexavar - only through the generosity of an anonymous benefactor, who paid her 9,000 drug bill, also ...
Stakeholder Opinions: Hepatocellular Carcinoma - Opportune indication ...
Pharmaceutical Business Review - The majority consist of targeted therapies, with Bayer-Schering/Onyx's Nexavar, Genentech/Roche's Avastin and OSI/Genentech/Roche's Tarceva considered to have the highest clinical and commercial potential. Why you should buy this report Evaluate ... ...
Pages: Start 1
